Fundraising FoxAmbient Biosciences
Ann Arbor, US · Delaware corporation
Find your way into Ambient Biosciences
Sign up to see every warm intro you have to Ambient Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ambient Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ambient Biosciences is a biotechnology company specializing in biostabilization technology. The company serves the broader life sciences and healthcare sectors with solutions to preserve biological materials and improve health outcomes globally.
Founders & leadership
MC
Matthew CobbettExecutive
RT
Richard TroyerExecutive
CM
Craig MansonExecutive
PS
Pravansu S. MohantyNamed on SEC filing
Board
PM
Paul MeisterBoard director
JH
Jack HoppinBoard director
WU
William U. ParfetBoard director
Reported raises · per SEC filings
Form D private placements$24.3M disclosed across 4 rounds · 2018–2024
▶$4.2MraisedDec 2024 · 9 investors · BiotechnologyRule 506(b)
▶$4.2MraisedDec 2024 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul MeisterDirector
- Matthew CobbettExecutive Officer
- Pravansu S. MohantyExecutive Officer, Director
- Richard TroyerExecutive Officer
- Jack HoppinDirector
- Craig MansonExecutive Officer
- William U. ParfetDirector
- Offering amount
- $5M
- Amount sold
- $4.2M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.2MraisedApr 2023 · 8 investors · BiotechnologyRule 506(b)
▶$9.2MraisedApr 2023 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William U. ParfetDirector
- Paul MeisterDirector
- Pravansu S. MohantyExecutive Officer
- Offering amount
- $12.2M
- Amount sold
- $9.2M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedDec 2021 · 1 investors · BiotechnologyRule 506(b)
▶$4MraisedDec 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carl Le SouefExecutive Officer, Director
- Pravansu S. MohantyExecutive Officer
- Alan TurfeExecutive Officer
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedSep 2018 · 1 investors · BiotechnologyRule 506(b)
▶$7MraisedSep 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carl Le SouefExecutive Officer, Director
- Pravansu S. MohantyExecutive Officer, Director
- Steve AnnearExecutive Officer
- Offering amount
- $7M
- Amount sold
- $7M
- Finders' fees
- $210K
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Ambient Biosciences.
Frequently asked questions
- What does Ambient Biosciences do?
- Ambient Biosciences is a biotechnology company specializing in biostabilization technology. The company serves the broader life sciences and healthcare sectors with solutions to preserve biological materials and improve health outcomes globally.
- How much funding has Ambient Biosciences raised?
- Ambient Biosciences has disclosed $24.3M raised across 4 rounds.
- Where is Ambient Biosciences headquartered?
- Ambient Biosciences is headquartered in Ann Arbor, US.